Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes
Clinical trial NCT01865305 · COMPLETED
Trial details
- NCT number
- NCT01865305
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2007-02-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.